Literature DB >> 8072376

Quantitative differences in interleukin-2 and interleukin-4 production by antigen-stimulated splenocytes from individually- and group-housed mice.

J D Karp1, N Cohen, J A Moynihan.   

Abstract

The effects of differential housing on T-helper (TH) cell activation were investigated. BALB/c and C57Bl/6 male mice housed 1 or 4 per cage were administered three i.p. injections of keyhole limpet hemocyanin (KLH) over several weeks. Effects of differential housing on in vitro antigen-specific interleukin (IL)-2 (a TH1 cell derived cytokine) and IL-4 (a TH2 cell derived cytokine) production were observed. BALB/c mice housed alone produced significantly more IL-4 than BALB/c mice housed in groups. C57Bl/6 mice housed alone produced significantly more IL-2 than C57Bl/6 mice housed in groups. Differential housing did not influence either IL-2 production among BALB/c mice or IL-4 production among C57Bl/6 mice. These data demonstrate that environmental conditions can influence cytokine production by both TH-1 dominant (C57Bl/6) and TH-2 dominant (BALB/c) mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072376     DOI: 10.1016/0024-3205(94)00562-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Encephalitozoon cuniculi Genotype III Evinces a Resistance to Albendazole Treatment in both Immunodeficient and Immunocompetent Mice.

Authors:  Bohumil Sak; Klára Brdíčková; Nikola Holubová; Dana Květoňová; Lenka Hlásková; Martin Kváč
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  Modification of Fecal Bacteria Counts and Blood Immune Cells in the Offspring of BALB/c and C57BL/6 Mice Obtained through Interstrain Mouse Embryo Transfer.

Authors:  Ekaterina A Litvinova; Galina V Kontsevaya; Elena N Kozhevnikova; Kseniya M Achasova; Ludmila A Gerlinskaya; Natalya A Feofanova; Mikhail P Moshkin
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-06-09       Impact factor: 1.232

Review 3.  Immunogenicity of Protein Pharmaceuticals.

Authors:  Robert Dingman; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-12-30       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.